Table 2.
Dropout | Non-Adherence | |||
---|---|---|---|---|
Hazard Ratio | 95% CI | Hazard Ratio | 95% CI | |
Cannabis Use | 6.4* | [1.2, 35.6] | 2.4*** | [1.5, 3.9] |
Medication (1=Olanazapine, 2=Risperidone) | 1.3 | [0.3, 4.6] | 1.1 | [0.7, 1.7] |
Site (0 = Hillside, 1 = Bronx) | 1.7 | [0.4, 8.0] | 5.4*** | [3.3, 8.9] |
Sex (1 = male, 2 = female) | 3.4 | [0.8, 14.4] | 0.6 | [0.3, 1.2] |
Age | 1.0 | [0.9, 1.2] | 1.0 | [1.0, 1.1] |
Socioeconomic Status | 0.9 | [0.9, 1.0] | 1.0 | [1.0, 1.0] |
Black | 1.2 | [0.1, 12.2] | 1.2 | [0.5, 2.8] |
Latino | 7.9 | [0.6, 104.2] | 0.5 | [0.2, 1.6] |
Race: (ref = white) | ||||
Asian | 4.7 | [0.4, 57.9] | † | |
Other | 2.0 | [0.1, 37.6] | 2.4+ | [0.9, 6.1] |
Model Fit χ2 | 18.9* | 92.1*** | ||
# Participants | 103 | 96 | ||
# “Failure” Events | 12 | 90 | ||
Months at risk | 986 | 927 | ||
Results illustrated in | Figure 1 | Figure 2 |
Note: Cannabis Use is a time-varying covariate; all other predictors are time-invariant.
p < .10
p < .05
p < .01
p < .001.
Asians had to be excluded from this analysis because there were no months during which an Asian participant both had valid data for cannabis use and was observed to be non-adherent.